BioSpace News Archive

CANAQUEST MEDICAL CORP. (OTC PINK:CANQF) (the “Company” or “CanaQuest”) today announced the signing of a Master Service Agreement with Neeka Health (“Neeka”) that will encompass multiple clinical studies to evaluate the efficacy of Mentanine® on targeted populations struggling with transitional issues.

Omeros Corporation (Nasdaq: OMER) today announced positive results from a pre-specified interim analysis of its ongoing Phase 1b clinical trial of OMS906, the company’s lead MASP-3 inhibitor, in complement-inhibitor-naïve adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening hemolytic blood disorder.

Pan-Biome Pharmaceuticals, Inc, is pleased to announce that its lead compound exhibited protective effects in a preclinical model of inflammatory colitis.

HealthTrackRx, the nation’s premier molecular diagnostic testing laboratory, announced that David B. Nash, MD, MBA, the Founding Dean Emeritus at the Jefferson College of Population Health, has joined its Strategic Advisory Board.

Biomind Labs Inc. is pleased to announce that it has commenced a Phase II clinical trial for its proprietary 5-Metoxi-N,N-dimethyltryptamine (" 5-MeO-DMT ")-based BMND08 candidate, a sublingual formulation for the potential treatment of anxiety and depression in Alzheimer’s disease.

Maxwell Biosciences (“Maxwell”), a preclinical drug discovery platform company focused on the development of synthetic compounds that mimic existing human biomolecules (biomimetic therapeutics) from our innate immune system, today announced the appointment of Maxie McFarland, MBA, as Senior Vice President of Corporate Development and Investor Relations.

The Insight Partners published latest research report on “Glycomics Market Share Report, Size, Growth, Trends, Price, Demand Forecasts to 2028 - COVID-19 Impact and Global Analysis By Product;

MicroVascular Tissues, Inc., a regenerative tissue company, announces effective 12/28/2022, Anthem Blue Cross Blue Shield and Amerigroup added coverage of mVASC® Microvascular Tissue Allograft for the treatment of diabetic foot ulcers.

The Insight Partners published latest research report on “Stem Cell Therapy Market Size Report, Revenue, Trends, Segments, Share & Forecasts to 2028 - COVID-19 Impact and Global Analysis By Type, Treatment, Application, End User and Geography”,

Karuna Integrated Clinical Services (KICS) has been launched today by a woman of color with an all-women C-Suite. The new company aims to provide specialized services to clients in the biotech and pharma industry, with a focus on strategic clinical operations